Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Lewy Body Disease

3,4-dihydroxyphenylacetic acid has been researched along with Lewy Body Disease in 4 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Lewy Body Disease: A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)

Research Excerpts

ExcerptRelevanceReference
"The most common is Parkinson's disease (PD), in which putamen dopamine content is drastically reduced."2.66The "Sick-but-not-Dead" Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases. ( Goldstein, DS, 2020)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Goldstein, DS4
Sharabi, Y2
Holmes, C1
Kopin, IJ1

Reviews

3 reviews available for 3,4-dihydroxyphenylacetic acid and Lewy Body Disease

ArticleYear
"Sick-but-not-dead": multiple paths to catecholamine deficiency in Lewy body diseases.
    Stress (Amsterdam, Netherlands), 2020, Volume: 23, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Catecholamines; Humans; Lewy Bodies; Lewy Body Disease; Stress, Psyc

2020
The "Sick-but-not-Dead" Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases.
    Seminars in neurology, 2020, Volume: 40, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Autonomic Nervous System Diseases; Dopamine; Humans; Lewy Body Disea

2020
The heart of PD: Lewy body diseases as neurocardiologic disorders.
    Brain research, 2019, 01-01, Volume: 1702

    Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Catecholamines; Dopamine; Heart; Humans; Lewy Bodie

2019

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Lewy Body Disease

ArticleYear
Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases.
    The Journal of clinical investigation, 2011, Volume: 121, Issue:8

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Catecholamines; Cytosol; Desipramine; Dopamine; Female; Fluori

2011